Biopharma in 2018: Vantage Releases Annual Analysis of Pharma, Biotech and Medtech Performance
Macroeconomic trends in Q4 wiped out biopharma’s stock market gains from earlier in 2018, with the S&P Pharmaceuticals Index the only major biopharma index to finish the year in the black. M&A and product licensing volumes were also down, despite notable deals such as Takeda’s $64bn acquisition of Shire and Bristol-Myers Squibb’s $1bn payment to Nektar. Deal-making slowed in the medtech sector too, with fewer acquisitions closed and a corresponding decrease in venture investment rounds.
- Falling share prices in Q4 turned a 15% nine-month climb for the Nasdaq Biotechnology Index into a 9% year-end decline, while the S&P Pharmaceuticals Index only managed a 5% gain.
- M&A activity hit its lowest level since 2009, with 173 total deals; licensing activity also dropped from 2017 levels by both deal count (112) and value measures ($4.94bn).
- The total value of medtech M&A deals came to $27.4bn, a precipitous decline from 2017’s figure of nearly $100bn.
Conversely, 2018 was a banner year for venture financing, with $16.8bn invested in drug development start-ups. Biotech IPOs set new records, with two of the biggest flotations – Moderna and Allogene – occurring in the final months of the year. Medtech IPOs also flourished in the fourth quarter, giving the smaller players a welcome cash injection. The FDA set records as well, with 62 novel drugs approved, and managed a slight reduction in average approval times.
- 37 drug developers raised over $100m in financing, more than double the number in 2017.
- Biotech IPOs raised a record $7.23bn, with the average amount raised tipping over $100m for the first time.
- A total of $695m was raised by device companies going public in the fourth quarter, more than any other three-month period since Vantage started tracking medtech listings in 2013.
- The FDA’s 2018 class of novel drugs is forecast to sell $24bn by 2023, including new migraine drugs Aimovig, Emgality and Ajovy; Alnylam's RNAi therapeutic Onpattro; and 17 new cancer drugs.
“The progress of biopharma and medtech companies last year paints a mixed picture,” said Amy Brown, co-author of the Vantage Pharma, Biotech and Medtech 2018 in Review report. “However, there are signs of health, if the industry is able to capitalize on them."
To download a complimentary copy of the report, visit http://www.evaluate.com/2018Review.
Vantage, formerly known as EP Vantage, provides award-winning, thought-provoking news and insights into current and future developments in the industry, and is the only pharmaceutical news service underpinned by Evaluate’s commercial intelligence. Visit www.evaluate.com/vantage for free access to daily, data-driven news for pharma, biotech, and medtech.
On Twitter: @Vantageanalysis.
About Evaluate Ltd
Evaluate provides trusted commercial intelligence for the pharmaceutical and medical device industries. For more information on how we give industry-leading companies the time and understanding to drive better decisions, visit us at www.evaluate.com.
On Twitter: @EvaluatePharma, @EvaluateMedtech
Evaluate and Vantage
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
BrandSafway Selects Rimini Street Application Management Services for Salesforce26.6.2019 16:00:00 EEST | Tiedote
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that BrandSafway, a global leader in access, industrial services and forming and shoring solutions for the industrial, commercial and infrastructure markets, has selected Rimini Street Application Management Services (AMS) for Salesforce for its Salesforce Sales Cloud system. BrandSafway has been leveraging Rimini Street support for its Oracle Database, E-Business Suite and JD Edwards software products since 2014, and now, BrandSafway is expanding its support service scope with Rimini Street to maximize the value and business impact of Salesforce and the Salesforce Sales Cloud system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005022/en/ BrandSafway Selects Rimini Street Application Management Servi
Jabil Packaging Solutions Launches New Sustainable Packaging Services; Accelerates Sustainable Packaging Innovation26.6.2019 15:45:00 EEST | Tiedote
Jabil Packaging Solutions (JPS), a division of Jabil Inc. (NYSE: JBL), today introduced a new suite of Sustainable Packaging Services , that enable packaged goods brands to design and deliver innovative new sustainable packaging formats into the marketplace at speed. Today, companies producing Consumer Packaged Goods (CPG) are at a turning point. They must find smart ways to make their products and packaging sustainable or face increasing regulations, taxes and pushback from consumers. Companies are trying to respond to sustainability mandates and want to do the right thing for the environment. Yet assessing what is needed, sourcing the right materials and designing products that meet their corporate sustainability goals is extremely complex due to the interdependencies and expertise required for end-to-end sustainable development. “For CPGs, there has never been a bigger challenge than the transition to a truly sustainable business model,” said Jason Paladino, JPS Vice President of Te
Moody’s Analytics Wins Enterprise-Wide Stress Testing Product of the Year at Risk Technology Awards26.6.2019 13:00:00 EEST | Tiedote
Moody’s Analytics, a global provider of financial intelligence, has won Enterprise-Wide Stress Testing Product of the Year at the 2019 Risk Technology Awards. It’s one of six categories won across finance, accounting, regulatory, and credit functions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005246/en/ Traditionally, stress testing exercises have required the participation of many groups within an institution and often took several months to complete. Today, banks must be able to respond to regulatory and management requests faster, while also extracting business value from the results. Moody’s Analytics helps banks overcome the challenges of stress testing. Our solutions improve data quality and integrity and make efficient use of resource and technology investments, while delivering industry-leading Moody’s Analytics modeling expertise. “Stress testing plays a critical role in how banks manage risk. Understandi
Tech Giant Alibaba Cloud Partners With UAE’s Group 42 to Host First MEA Internet Summit26.6.2019 12:19:00 EEST | Tiedote
Alibaba Cloud, the data intelligence backbone of Alibaba Group, today held its inaugural Middle East and Africa (MEA) Internet Summit in partnership with UAE-based Artificial Intelligence (AI) and Cloud Computing leader Group 42. Drawing the participation of tech experts and executives from the region’s top 100 internet companies, the summit took place during the Ghyma Conference 2019. Among the distinguished guests were HE Saif Mohammed Al Hajri, Chairman of the Department of Economic Development Abu Dhabi, His Excellency Mohammed Gheyath, Executive Director Information Security Operations, Abu Dhabi Digital Authority, Ibrahim Ajami, Head of Mubadala Ventures, Peng Xiao, CEO of Group 42, and Selina Yuan, President of Alibaba Cloud Intelligence International. Panelists and speakers covered an extensive range of topics over 10 keynote speeches. These included maximising the potential of cloud and AI, leveraging the internet to thrive in the new digital age, taking e-commerce to the next
SIGMOLECS®: the Most Advanced Technology Available for Regenerative Medicine26.6.2019 12:00:00 EEST | Tiedote
Contrad Swiss, a pharmaceutical company focused on breakthrough, innovative products that reframe the world of medicine, announces a new partnership with Dr JO Serrentino to bring to the market effective biomedical remedies unlike any other. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005031/en/ Photo by Contrad Swiss SIGMOLECS® Technology was conceived and engineered by Dr Serrentino exclusively for Contrad Swiss. SIGMOLECS® uses the highest bioavailable signaling molecules to summon and target biological pathways for precise programming at the cellular level. The result is like a program code of the cells, deploying them to organize into specific patterns. SIGMOLECS® talks to the cells in their language. ACTV8SKN® – Actuator - contains the exclusive SIGMOLECS® Technology. ACTV8SKN® is an odorless fluid gel of peptide-bonded amino acids, specifically engineered for a complete signaling spectrum that awakens cell cy
Secure-24, an NTT Communications Company, to Acquire Symmetry, Leading SAP Managed Service Provider in the U.S.26.6.2019 09:00:00 EEST | Tiedote
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, announced today that Secure-24 Intermediate Holdings, Inc. (Secure-24), wholly owned subsidiary of NTT Com, entered into a definitive agreement on June 26 (Japan Standard Time), pursuant to which Secure-24 will wholly acquire Symmetry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190625006084/en/ Managed services are one of the key capabilities NTT Com is strengthening to support its clients’ digital transformations as a DX Enabler™. Secure-24 has been playing key roles for delivering such capabilities especially in the U.S. market. Symmetry possesses extensive expertise in SAP managed services, which it delivers to large enterprise clients in diverse industries including consumer products, life s
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme